04:57 AM EDT, 08/21/2025 (MT Newswires) -- Ascentage Pharma Group International ( AAPG ) reported an H1 loss late Wednesday of 1.73 Chinese renminbi ($0.24) per diluted share, compared with earnings of 0.55 renminbi a year earlier.

Revenue for the half-year ended June 30 was 233.7 million renminbi, down from 823.7 million renminbi a year earlier.

Analysts' estimates were not readily available for comparison.